Research Grade Biosimilars

Apart from their medicinal uses, Biosimilar Monoclonal Antibodies have shown success in clinical environments and have significantly helped to progress laboratory research. Researchers rely on these mAbs, often referred to as biosimilars, as critical tools for exploring innovative therapies and identifying off-target uses. With established data on their toxicity and efficacy, these biologics serve as reliable benchmarks, enabling researchers to expedite their transition from initial studies to clinical applications.

ProSci-Inc offers an extensive catalogue of over 800 research-based biosimilar antibodies, empowering scientists across the globe with cutting-edge research tools. Complementing this vast selection, ProSci’s dedicated team of custom antibody specialists provides unmatched expertise in antibody design, development, purification, and scale-up processes to support advanced research needs.